Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors

A poster titled “Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors: A Real-World Cohort Study” was presented at the ASCO 2026 Annual Meeting by author Sandeep Kumar Jain, MD on behalf of co-authors Jeremy Coyle, Jananee Muralidharan, Daniel D. Rodriguez-Romero, Honor Magon, C. William Pike, and […] The post Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors appeared first on Atropos Health .